False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma
dc.contributor.author | Ozcan, Z | |
dc.contributor.author | Erenel, G | |
dc.contributor.author | Aksoylar, S | |
dc.contributor.author | Kansoy, S | |
dc.contributor.author | Burak, Z | |
dc.contributor.author | Ozkilic, H | |
dc.date.accessioned | 2019-10-27T11:50:48Z | |
dc.date.available | 2019-10-27T11:50:48Z | |
dc.date.issued | 1999 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Tc-99m sestamibi, originally developed for myocardial studies, has been used as a tumor-seeking agent. Recently, the agent also was reported to be a functional tracer to predict multidrug resistance-related p-glycoprotein expression in tumor tissue. The current report presents the authors' experience with sestamibi tumor scintigraphy in a neuroblastoma. Although I-131 MIBG tumor imaging and Tc-99m MDP bone scanning accurately demonstrated the extent of the disease, Tc-99m sestamibi showed no accumulation in primary and metastatic foci. Lack of sestamibi uptake was initially thought to be suggestive of failure to respond to chemotherapy because of p-glycoprotein expression. However, the patient responded well to chemotherapy and complete remission was achieved. The failure of Tc-99m sestamibi to detect a neuroblastoma and the lack of sestamibi accumulation in the tumor may not always be related to chemotherapy resistance. | en_US |
dc.identifier.doi | 10.1097/00003072-199904000-00011 | en_US |
dc.identifier.endpage | 270 | en_US |
dc.identifier.issn | 0363-9762 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 10466525 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 267 | en_US |
dc.identifier.uri | https://doi.org/10.1097/00003072-199904000-00011 | |
dc.identifier.uri | https://hdl.handle.net/11454/34385 | |
dc.identifier.volume | 24 | en_US |
dc.identifier.wos | WOS:000079440800011 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Clinical Nuclear Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | neuroblastoma | en_US |
dc.subject | radionuclide imaging | en_US |
dc.subject | Tc-99m sestamibi | en_US |
dc.title | False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma | en_US |
dc.type | Article | en_US |